Cobram Estate Olives (CBO) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
9 Jul, 2026Executive summary
Achieved record FY2024 results with olive oil sales revenue of AUD 220.9 million, up 134.6% year-over-year, and net profit after tax of AUD 18.5 million, driven by strong growth in both Australia and the USA.
EBITDA rose 163.4% to AUD 66.7 million, supported by improved product mix and higher average prices.
Packaged goods sales accounted for 87.5% of olive oil sales, with significant growth in both Australian and US markets.
Maintained market leadership in Australia, with Cobram and Red Island holding a combined 37.9% value share.
Continued investment in growth assets and sustainability initiatives in both Australia and the USA, positioning for future expansion.
Financial highlights
Group olive oil sales revenue reached AUD 220.9 million, up 134.6% year-over-year; global packaged goods sales AUD 193.4 million, up 138.4%.
EBITDA of AUD 66.7 million, up 163.4%; net profit after tax AUD 18.5 million, up 140.1% year-over-year.
Record operating cash flow of AUD 64.1 million, up 18.4% from the previous year.
Net assets increased from AUD 287 million to AUD 322 million.
Australian packaged goods sales AUD 142.9 million (+128.1%), USA packaged goods sales AUD 50.5 million (+178.9%).
Outlook and guidance
FY2025 is an "on-year" for Australian groves; EBITDA expected to be materially higher, subject to agricultural risks.
Operating cash flow projected to remain strong, fully funding planned U.S. expansion.
U.S. packaged goods price increase of 15% effective September 2024.
Board anticipates a fully franked dividend of AUD 0.033 per share in December 2024.
Australian CapEx to shift to maintenance mode; U.S. growth to drive future capital projects.
Latest events from Cobram Estate Olives
- Sales and EBITDA surged, led by packaged goods and U.S. expansion, with a strong FY2025 outlook.CBO
H1 20258 Jul 2026 - Record sales, profit, and growth initiatives drive a positive outlook.CBO
AGM 20248 Jul 2026 - Record profit, strong sales growth, and U.S. expansion mark a transformative year.CBO
H2 202516 Jun 2026 - EBITDA ahead of guidance, net loss widened, capital raised for U.S. expansion and acquisition.CBO
H1 202612 Jun 2026 - Record profit, U.S. expansion, and sustainability drive long-term growth and shareholder value.CBO
AGM 202513 Nov 2025 - Major capital raise to fund rapid USA expansion, targeting 3,600 hectares and 9M+ litres of oil.CBO
Investor Presentation9 Sep 2025